Vifor Fresenius Medical Care Renal Pharma - partner of choice for renal pharmaceuticals and innovative, patient-centric solutions.
www.viforpharma.com Vifor Fresenius Medical Care Renal Pharma is a rapidly-growing international company that focuses on nephrology. We combine the strengths of our two shareholders: Vifor Pharma, a pharmaceutical company specialising in the treatment of iron deficiency, and Fresenius Medical Care, one of the world’s leading providers of expert patient care and dialysis services.
www.viforpharma.com
www.shptchallenges.com
AMOUNT: 40.000 Euros
Vifor Fresenius Medical Care Renal Pharma supports the Nephro Update Europe 2021 as a Gold Partner.
Vifor Fresenius Medical Care Renal Pharma supports the Nephro Update Europe 2021 as a Gold Partner.
Medtronic is the global leader medical technology, alleviating pain, restoring health an extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies - every three seconds, another life is improved by a Medtronic product or therapy.
www.medtronic.com AMOUNT: 20.000 Euros
Medtronic supports the Nephro Update Europe 2021 as Silver Partner.
Medtronic supports the Nephro Update Europe 2021 as Silver Partner.
The Boehringer Ingelheim and Lilly Alliance is an international pharmaceutical company alliance which is doing business in the development and marketing of new pharmaceutical products, in particular in the therapeutical area of Cardio-Renal-Metabolism. As an innovative, research-driven alliance it feels responsible for the support of research & development and education of health-care professionals.
www.boehringer-ingelheim.com AMOUNT: 10.000 Euros
Boehringer Ingelheim Lilly Alliance supports the Nephro Update Europe 2021 as Partner.
Boehringer Ingelheim Lilly Alliance supports the Nephro Update Europe 2021 as Partner.
Hansa Biopharma is leveraging its proprietary enzyme technology platform to enable immunomodulatory treatments for transplants, rare immunoglobulin G (IgG)-mediated autoimmune conditions, gene therapy and cancer.
www.hansabiopharma.com AMOUNT: 10.000 Euros
Hansa Biopharma supports the Nephro Update Europe 2021 as Partner.
Hansa Biopharma supports the Nephro Update Europe 2021 as Partner.
